Nicola Nicolai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nicola nicolai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nicola Nicolai Today - Breaking & Trending Today

Benetti Launches 203-Foot Custom Build

Benetti Yachts launched its 203-foot FB283, a fully custom superyacht with exteriors and interiors by Giorgio Casetta, and hull lines by Van Oosanen. ....

Giorgio Cassetta , Nicola Nicolai , Subscribeto Yachting , Van Oossanen Naval , Nicolai Yacht Consulting ,

Treatment De-Escalation Shows Promise in Testicular Cancer

Early trial misses primary PFS endpoint, but 'favorable' outcomes seen nonetheless ....

United States , Patrizia Giannatempo , Alexandros Papachristofilou , Mike Bassett , Nicola Nicolai , Swiss Group For Clinical Cancer Research , National Cancer Institute , University Hospital Basel , German Testicular Cancer Study Group , Cancer Institute , Swiss Group , Clinical Cancer Research , German Testicular Cancer Study ,

De-escalation Strategy in Seminoma: An Alternative Option?

A de-escalation strategy in stage IIA and IIB seminoma had a progression-free survival outcome similar to that of standard care and could potentially offer an alternative option. ....

Patrizia Giannatempo , Alexandros Papachristofilou , Nicola Nicolai , Rising Tide Foundation For Clinical Cancer Research , National Cancer Institute , University Hospital Basel , Department Of Radiation Oncology , Cancer Institute , With Lower , Radiation Oncology , Swiss State Secretariat , Rising Tide Foundation , Clinical Cancer , Malignant Testicular Neoplasm , Testicular Cancer , Ancer Testicular , Esticular Seminoma , Combination Chemotherapy ,

GSRGT 2020: Evolution of Systemic Therapies and the Landscape of Clinical Trials Enrolling Patients

GSRGT 2020: Evolution of Systemic Therapies and the Landscape of Clinical Trials Enrolling Patients
(UroToday.com) To discuss the evolution of systemic therapies and the landscape of clinical trials among patients with penile cancer, Dr. Philippe Spiess, the co-Course Director of the Global Society of Rare Genitourinary Tumors (GSRGT) 2020 Virtual Summit, invited Dr. Jad Chahoud, his colleague from the Moffitt Cancer Center.
Dr. Chahoud started by highlighting that penile cancer is a rare disease in the US, representing 0.7% of all cancer, with high-risk HPV responsible for ~50% of all penile squamous cell carcinoma. The majority of these patients will present with localized or locally advanced disease whereby platinum-based combination chemotherapy remains the front-line therapy. The InPACT trial is actively enrolling patients to determine the frontline therapy for locally advanced penile cancer, given there have been limited treatment advancements in the last decade. ....

United States , Patrizia Giannatempo , Zachary Klaassen , Daniele Raggi , Andrea Necchi , Philippe Spiess , Michaelb Williams , Sijin Wen , Curtisa Pettaway , William Osai , Nicola Nicolai , Danai Daliani , Giuseppina Calareso , Michael Kincaid , Bju International , Augusta University Medical College Of Georgia , Moffitt Cancer Center , Global Society Of Rare Genitourinary Tumors , Department Of Genitourinary Oncology , Georgia Cancer Center , National Comprehensive Cancer Network , Course Director , Global Society , Rare Genitourinary Tumors , Jad Chahoud , Moffitt Cancer ,